Roche registers giredestrant Phase 3 trial; six other studies updateNov 6Weekly roundup, 16 itemsAbbViealectinibUpdated
Roche group registers Phase III UC trial, GA-AMD study; AD extension stays activeOct 30Weekly roundup, 7 itemsafimkibartastegolimab
Artiva Biotherapeutics halts AlloNK development, cuts staff by 94%Oct 27Quarterly updateArtiva Biotherapeutics, Inc.Biogen
Sign inSign in